US6004807A
(en)
*
|
1992-03-30 |
1999-12-21 |
Schering Corporation |
In vitro generation of human dendritic cells
|
EP0633929B1
(en)
*
|
1992-04-01 |
2004-03-03 |
The Rockefeller University |
METHOD FOR $i(IN VITRO) PROLIFERATION OF DENDRITIC CELL PRECURSORS AND THEIR USE TO PRODUCE IMMUNOGENS
|
US5651993A
(en)
|
1992-11-18 |
1997-07-29 |
Yale University |
Specific immune system modulation
|
CA2158281A1
(en)
*
|
1993-03-15 |
1994-09-29 |
Jay A. Berzofsky |
Peptide coated dendritic cells as immunogens
|
EP0765386B1
(en)
*
|
1994-06-14 |
2014-12-10 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods for in vivo t cell activation by antigen-pulsed dendritic cells
|
US6300090B1
(en)
|
1994-07-29 |
2001-10-09 |
The Rockefeller University |
Methods of use of viral vectors to deliver antigen to dendritic cells
|
US5643786A
(en)
*
|
1995-01-27 |
1997-07-01 |
The United States Of America As Represented By The Department Of Health And Human Services |
Method for isolating dendritic cells
|
US6010905A
(en)
*
|
1995-01-27 |
2000-01-04 |
The United States Of America As Represented By The Department Of Health & Human Services |
Method for inducing monocytes to exhibit the phenotype of activated myeloid dendritic cells
|
US6340981B1
(en)
|
1997-06-30 |
2002-01-22 |
Sun Microsystems, Inc. |
Method and apparatus for stroke substitution
|
US6121044A
(en)
*
|
1995-07-12 |
2000-09-19 |
Dendreon Corporation |
Potent antigen presenting cell composition
|
US5788963A
(en)
*
|
1995-07-31 |
1998-08-04 |
Pacific Northwest Cancer Foundation |
Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy
|
US5985270A
(en)
*
|
1995-09-13 |
1999-11-16 |
Fordham University |
Adoptive immunotherapy using macrophages sensitized with heat shock protein-epitope complexes
|
US7659119B2
(en)
|
1996-02-12 |
2010-02-09 |
Argos Therapeutics, Inc. |
Method and compositions for obtaining mature dendritic cells
|
US5849589A
(en)
*
|
1996-03-11 |
1998-12-15 |
Duke University |
Culturing monocytes with IL-4, TNF-α and GM-CSF TO induce differentiation to dendric cells
|
US7381407B1
(en)
|
1996-03-25 |
2008-06-03 |
Medarex, Inc. |
Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
|
US6962981B1
(en)
|
1996-03-25 |
2005-11-08 |
Medarex, Inc. |
Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
|
WO1998006823A2
(en)
*
|
1996-08-14 |
1998-02-19 |
Nexell Therapeutics Inc. |
Cytokine-free culture of dendritic cells
|
US6458585B1
(en)
*
|
1996-08-14 |
2002-10-01 |
Nexell Therapeutics Inc. |
Cytokine-free culture of dendritic cells
|
US6017540A
(en)
|
1997-02-07 |
2000-01-25 |
Fordham University |
Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes
|
US5830464A
(en)
*
|
1997-02-07 |
1998-11-03 |
Fordham University |
Compositions and methods for the treatment and growth inhibition of cancer using heat shock/stress protein-peptide complexes in combination with adoptive immunotherapy
|
US20050169898A1
(en)
|
1997-04-15 |
2005-08-04 |
Jianlin Gong |
Cell fusions and methods of making and using the same
|
AU7499498A
(en)
|
1997-05-21 |
1998-12-11 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Methods and compositions for making dendritic cells from expanded populations ofmonocytes and for activating t cells
|
US6713250B1
(en)
|
1997-08-08 |
2004-03-30 |
The Research Foundation Of State University Of New York |
Identification of human allergens and T-lymphocyte antigens in vitro
|
EP1015003A1
(en)
*
|
1997-09-19 |
2000-07-05 |
Johnson & Johnson Research Pty Ltd. |
Transgenic autologous t-cell therapy in humans, and related compositions and kits
|
AU9801798A
(en)
*
|
1997-10-14 |
1999-05-03 |
Ludwig Institute For Cancer Research |
Interferon-gamma regulatory factors
|
US6274378B1
(en)
|
1997-10-27 |
2001-08-14 |
The Rockefeller University |
Methods and compositions for obtaining mature dendritic cells
|
AU1457199A
(en)
|
1997-11-12 |
1999-05-31 |
University Of Pittsburgh |
Isolation, characterization, and identification of dendritic like cells and methods of using same
|
EP1071436A4
(en)
*
|
1998-01-26 |
2003-08-27 |
Dana Farber Cancer Inst Inc |
Immune effector cell hybrids
|
AU2872199A
(en)
|
1998-02-20 |
1999-09-06 |
Rockefeller University, The |
Apoptotic cell-mediated antigen presentation to dendritic cells
|
US6849452B1
(en)
*
|
1998-03-03 |
2005-02-01 |
Institut Gustave Roussy |
Methods for activating natural killer (NK) cells and means for carrying out said methods
|
FR2782524B1
(en)
*
|
1998-08-21 |
2002-07-19 |
Roussy Inst Gustave |
METHODS OF ACTIVATION OF NATURAL KILLER CELLS (NK) AND MEANS OF IMPLEMENTATION
|
FR2775692B1
(en)
*
|
1998-03-03 |
2000-06-16 |
Roussy Inst Gustave |
METHODS FOR ACTIVATING NATURAL KILLER (NK) CELLS AND MEANS OF IMPLEMENTATION
|
AU3456099A
(en)
*
|
1998-03-31 |
1999-10-18 |
Geron Corporation |
Methods and compositions for eliciting an immune response to a telomerase antigen
|
US7402307B2
(en)
|
1998-03-31 |
2008-07-22 |
Geron Corporation |
Method for identifying and killing cancer cells
|
US6835550B1
(en)
*
|
1998-04-15 |
2004-12-28 |
Genencor International, Inc. |
Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins
|
FR2777906B1
(en)
*
|
1998-04-27 |
2001-05-18 |
Transfusion Sanguine De Lyon E |
PRODUCTION OF HUMAN DENDRITIC CELLS DERIVED FROM MONOCYTES
|
AU4603499A
(en)
*
|
1998-06-26 |
2000-01-17 |
Joergen Agnholt |
Methods of expanding and selecting disease associated t-cells
|
US20020142974A1
(en)
*
|
1998-09-11 |
2002-10-03 |
Leonard D. Kohn |
Immune activation by double-stranded polynucleotides
|
WO2000062818A1
(en)
|
1999-04-20 |
2000-10-26 |
Richard Leslie Edelson |
Differentiation of monocytes into functional dendritic cells
|
US7713739B1
(en)
|
2000-11-17 |
2010-05-11 |
Novartis Vaccines And Diagnostics, Inc. |
Microparticle-based transfection and activation of dendritic cells
|
FR2803308B1
(en)
*
|
1999-12-30 |
2005-08-26 |
Centre Nat Rech Scient |
TH1 TYPE-SPECIFIC CD4 T-LYMPHOCYTE LINES AND METHOD FOR THEIR EX VIVO INDUCTION
|
FR2803307A1
(en)
*
|
1999-12-30 |
2001-07-06 |
Centre Nat Rech Scient |
SPECIFIC TH1 TYPE CD4 T LYMPHOCYTES LINES AND METHOD FOR THEIR EX VIVO INDUCTION
|
GB0007088D0
(en)
*
|
2000-03-23 |
2000-05-17 |
Torsana A S |
Detection of immunological memory determining the position of loci of pathologyand therapeutic t-cell conjugates
|
JP4841794B2
(en)
|
2000-05-12 |
2011-12-21 |
ノースウエスト バイオセラピューティクス,インコーポレイティド |
Methods for increasing class I presentation of exogenous antigens by human dendritic cells
|
AU2001288863A1
(en)
*
|
2000-09-15 |
2002-03-26 |
Ortho-Mcneil Pharmaceutical, Inc. |
Compositions and methods for inducing specific cytolytic t cell responses
|
US7566568B2
(en)
*
|
2001-04-27 |
2009-07-28 |
Istituto Superiore Di Sanita |
Method for generating highly active human dendritic cells from peripheral blood mononuclear cells
|
PT1407004E
(en)
|
2001-05-15 |
2009-08-31 |
Ortho Mcneil Janssen Pharm |
Ex-vivo priming for generating cd40-ligand specific cytotoxic t lymphocytes to treat autoimmune and allergic disease
|
EP2305276A3
(en)
|
2001-12-07 |
2011-09-21 |
Cytori Therapeutics, Inc. |
Processed lipoaspirate cells for use in therapy
|
US7585670B2
(en)
|
2001-12-07 |
2009-09-08 |
Cytori Therapeutics, Inc. |
Automated methods for isolating and using clinically safe adipose derived regenerative cells
|
US8105580B2
(en)
|
2001-12-07 |
2012-01-31 |
Cytori Therapeutics, Inc. |
Methods of using adipose derived stem cells to promote wound healing
|
US7771716B2
(en)
|
2001-12-07 |
2010-08-10 |
Cytori Therapeutics, Inc. |
Methods of using regenerative cells in the treatment of musculoskeletal disorders
|
US9597395B2
(en)
|
2001-12-07 |
2017-03-21 |
Cytori Therapeutics, Inc. |
Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
|
US20050095228A1
(en)
|
2001-12-07 |
2005-05-05 |
Fraser John K. |
Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders
|
US20050084967A1
(en)
|
2002-06-28 |
2005-04-21 |
Xcyte Therapies, Inc. |
Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation
|
JP5249587B2
(en)
|
2005-02-18 |
2013-07-31 |
メダレックス, インク. |
Monoclonal antibody against prostate specific membrane antigen (PSMA) lacking fucosyl residues
|
US8414899B2
(en)
|
2006-04-11 |
2013-04-09 |
Yeda Research And Development Co. Ltd. |
Vaccines comprising multimeric HSP60 peptide carriers
|
DE102006060824B4
(en)
*
|
2006-12-21 |
2011-06-01 |
Johannes-Gutenberg-Universität Mainz |
Detection of Individual T Cell Response Patterns Against Tumor-associated Antigens (TAA) in Tumor Patients as a Basis for Individual Therapeutic Vaccination of Patients
|
WO2010021993A1
(en)
|
2008-08-19 |
2010-02-25 |
Cytori Therapeutics, Inc. |
Methods of using adipose tissue-derived cells in the treatment of the lymphatic system and malignant disease
|
MX339769B
(en)
|
2009-05-01 |
2016-06-08 |
Bimini Tech Llc |
Systems, methods and compositions for optimizing tissue and cell enriched grafts.
|
US8467973B2
(en)
*
|
2009-07-28 |
2013-06-18 |
Promising Future, Llc |
Pairing processes for preparing alloreactive cytotoxic T cells
|
JP6081483B2
(en)
|
2011-12-12 |
2017-02-15 |
セル・メディカ・リミテッド |
The process of proliferating T cells
|
GB201121308D0
(en)
|
2011-12-12 |
2012-01-25 |
Cell Medica Ltd |
Process
|
DK3591047T3
(en)
|
2012-02-09 |
2022-10-24 |
Baylor College Medicine |
Peptide mixtures for the generation of multiviral CTLs with broad specificity
|
WO2016179475A1
(en)
*
|
2015-05-07 |
2016-11-10 |
Baylor College Of Medicine |
Dendritic cell immunotherapy
|
JP6999941B2
(en)
|
2015-09-18 |
2022-02-10 |
ベイラー カレッジ オブ メディスン |
Identification of immunogenic antigens from pathogens and their correlation with clinical efficacy
|